US Taskforce Guidelines

USPSTFguide has the sole purpose of organizing the information in an easy to access, searchable database for all healthcare providers. The all in one well tabulated guideline that is relevant, current, and most useful.

Private vs Medicaid Out-of-Pocket Statin Costs After 2016 USPSTF Recommendation
on October 10, 2025
This economic evaluation compares out-of-pocket costs for statins among privately insured vs Medicaid enrollees before and after the 2016 US Preventive Services Task Force (USPSTF) grade B recommendation.
Breast Cancer Outcomes by Mammography Participation in Immediate Past Screening
on October 3, 2025
This cohort study investigates whether women diagnosed with screen-detected breast cancer who did not attend the screening round immediately before the screening that diagnosed their cancer have differences in tumor characteristics and survival compared with women who attended both screening rounds.

Characterizing Surveillance Recommendations From NCCN Guidelines
on October 29, 2025
This quality improvement study examines National Comprehensive Cancer Network clinical guidelines for cancer surveillance by type and characterizes specificity and length of recommended treatments.
2025 Guidelines for the Management of Benign Breast Fibroepithelial Lesions
on October 22, 2025
This Special Communication discusses the development of evidence-informed, consensus and expert opinion-based guidelines for the management of benign fibroepithelial lesions of the breast.
ACIP Standards for Assessing Evidence
on October 22, 2025
This Viewpoint discusses Institute of Medicine (IOM) standards for clinical guideline development and measures taken by the Advisory Committee on Immunization Practices (ACIP) to bring ACIP in line with those standards; describes ways in which these standards and measures have not implemented by ACIP; and calls for ACIP recommendations to meet IOM standards.

Incomplete Family History and Algorithmic Criteria for Hereditary Cancer Evaluation
on October 28, 2025
This cross-sectional study evaluates whether a clinical decision support algorithm can identify patients with incomplete electronic health record documentation of family history who are eligible for hereditary cancer genetic evaluation.
Risk Prediction Model for Heart Failure or Cardiomyopathy After Breast Cancer Treatment
on October 23, 2025
This longitudinal cohort study investigates whether a risk prediction model can estimate the 10-year risk of developing heart failure or cardiomyopathy in women receiving systemic treatment for invasive early-stage breast cancer.